Novartis' iron drug Exjade will carry black-box warning

02/18/2010 | Reuters

The FDA announced that Novartis' iron treatment Exjade will come with a black-box warning stating the risk of potentially fatal renal impairment. The drug is approved to level the amount of excess iron caused by blood transfusion.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care